speb/financial-data huggingface dataset:
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 4348574000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 4348574000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -553796000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Net Income: 386599000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 386599000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 386599000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 386599000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 386599000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 386599000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 386599000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: 22253000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 150889000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 22253000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -31378000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 6512510000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -144810000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 3468933000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 38879000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 38879000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 595217000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Normalized Income: 397682723.17
CMGS.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 557075000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Operating Income: 493628000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 2875253000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 1349790000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 103945000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -9847000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Other Gand A: 172783000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: -14378000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 914000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 146941000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 74231000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Other Properties: 6512510000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 689125000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Other Special Charges: 8210000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Payables: 263553000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 603289000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Pretax Income: 501503000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: -1294000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -4000000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -144810000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 101594000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 2121631000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 87211000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Rent Expense Supplemental: 149841000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -553796000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 1369418000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 154889000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 172783000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 1349790000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Special Income Charges: -14378000.00
CMGS.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 37601000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 3490872000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 3468933000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -3294276.83
CMGS.TO income_statement (quarterly, 2025-03-31) — Tax Provision: 114904000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.23
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 0.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 9044094000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 3490872000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 4633079000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 3490872000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 2381625000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 5553222000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 7382446000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 4461684000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 479250000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 46147000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: -14378000.00
CMGS.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -14378000.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 0.00
CMGS.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 570110000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 263096000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 3063393000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 216347000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 105004000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 2157080000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 5038000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 4766897809.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Basic EPS: 0.09
CMGS.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 756123000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -160585000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 4780586000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 13414000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 844524000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1546492000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 744101000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Cash Financial: 100423000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -443660000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 1988000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 561327000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -848000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 84633000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Change In Inventory: 958000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 77994000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -56748000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -121364000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Change In Payable: -848000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 83785000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 6142000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: -3293000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -12526000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -3293000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: 119655000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 13414000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 3528195000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -443259000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2225163000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 422037000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 1869125000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 287252000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 287252000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 206635000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 206635000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1132271000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -2561000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Deferred Tax: -2561000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 90945000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 90945000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 90945000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 90945000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 4785615155.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.09
CMGS.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 436127000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — EBIT: 575134000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — EBITDA: 666079000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -550000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 875228000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -443660000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 400742000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -7341000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 172151000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Goodwill: 21939000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 21939000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 6707418000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Gross Profit: 838230000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 5467000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 270573000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Interest Income: 18355000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 18355000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Inventory: 40402000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 3528195000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 1988000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 518680000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 4493334000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 4493334000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -443259000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Net Income: 436127000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 436127000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 436127000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 436127000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 436127000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 436127000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 436127000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: 18355000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 162573000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 18355000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -401000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 6707418000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -160585000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 3506256000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 36297000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 36297000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 682156000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Normalized Income: 448265135.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 561327000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Operating Income: 575134000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 3063393000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 1341425000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 96506000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -7341000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Other Gand A: 172151000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: -16077000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 6708000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 151632000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 78697000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Other Properties: 6707418000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 701968000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Other Special Charges: 10610000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Payables: 216347000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 638384000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Pretax Income: 577412000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 47000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -2500000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -160585000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 185725000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2225163000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 90945000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Rent Expense Supplemental: 154250000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -443259000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 1365042000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 165073000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 172151000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 1341425000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Special Income Charges: -16077000.00
CMGS.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 37549000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 3528195000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 3506256000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -3938865.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 141285000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.24
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 80721000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 9268794000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 3528195000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 4780586000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 3528195000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 2488259000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 5740599000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 7399669000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 4608328000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 559057000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: -16077000.00
CMGS.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -16077000.00
CMGS.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 736854000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — +Operating Expense: 237266000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — +Total Revenue: 3003444000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 260190000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 95844000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 2177774000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 7215000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 875228000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -163486000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 4980117000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 13257000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 698743000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1421274000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Cash Equivalents: 610624000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Cash Financial: 88119000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -700468000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -15403000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 569680000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 16944000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -35985000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Change In Inventory: -6085000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 80537000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -65366000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -26954000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Change In Payable: 16944000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -19041000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -5850000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Change In Receivables: 10036000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -32723000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 10036000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -146191000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Common Stock: 13257000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 3221838000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -686665000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 2267861000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 390117000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Current Assets: 1773780000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 293027000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 293027000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 206730000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 206730000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1150064000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 104175000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Deferred Tax: 104175000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 90524000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 90524000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 90524000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 90524000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 382103000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — EBIT: 498317000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — EBITDA: 588841000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 599000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — End Cash Position: 729636000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -700468000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 406194000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -7927000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 146742000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Goodwill: 21939000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 21939000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 6979104000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Gross Profit: 735583000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 7404000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 39677000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Interest Income: 19789000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 19789000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Inventory: 46436000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 3221838000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -15403000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 347694000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 4687090000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 4687090000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -686665000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Net Income: 382103000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 382103000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 382103000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 382103000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 382103000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 382103000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 382103000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Net Interest Income: 19789000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 148083000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 19789000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -13803000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Net PPE: 6979104000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -163486000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 3199899000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 140480000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 140480000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 609986000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Normalized Income: 398363505.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 569680000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Operating Income: 498317000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 3003444000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 1325678000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 100542000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -7927000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Other Gand A: 146742000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: -21145000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -51000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 159331000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 82376000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Other Properties: 6979104000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 722531000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Other Special Charges: 13741000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Payables: 260190000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 650307000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Pretax Income: 496961000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: -379000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -9219000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -163486000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 205528000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 2267861000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 90524000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Rent Expense Supplemental: 158314000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -686665000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 1038734000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 157302000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 146742000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 1325678000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Special Income Charges: -21145000.00
CMGS.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 18816000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 3221838000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 3199899000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -4884495.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Tax Provision: 114858000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.23
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 109684000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 9281848000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 3221838000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 4980117000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 3221838000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 2505127000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 6060010000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 7508068000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 4909946000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 477172000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: -21145000.00
CMGS.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -21145000.00
CMGS.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: 623716000.00
CMGS.TO income_statement (annual, 2025-12-31) — +Operating Expense: 1013399000.00
CMGS.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 253043000.00
CMGS.TO income_statement (annual, 2025-12-31) — +Total Revenue: 11925601000.00
CMGS.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 2983511000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 212813000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 212813000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 156466000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 156466000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -2531317000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -2531317000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 2204944000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 2204944000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -1670000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -1670000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 26576000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 8305000.00
CMGS.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 4739893936.00
CMGS.TO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 4660271674.00
CMGS.TO income_statement (annual, 2025-12-31) — Basic EPS: 0.32
CMGS.TO income_statement (quarterly, 2025-12-31) — Basic EPS: 0.07
CMGS.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 778379000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 729636000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -666336000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -197455000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 5075814000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 5075814000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 13044000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 13044000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 350545000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 350545000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1044607000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1044607000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Cash Equivalents: 287908000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 287908000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Cash Financial: 62637000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Cash Financial: 62637000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -2470898000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -741596000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -35082000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -27746000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 2113926000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 425844000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Change In Account Payable: -7449000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -36753000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -22612000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 35936000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Change In Inventory: -710000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Change In Inventory: -3118000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 327530000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 96398000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -262420000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -85646000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 16585000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 82527000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Change In Payable: -7449000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Change In Payable: -36753000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -30061000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -817000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -33042000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -23586000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Change In Receivables: -11383000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: -61365000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: 6499000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 4393000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -11383000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -61365000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Changes In Cash: -392054000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -343498000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Common Stock: 13044000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 13044000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 2830607000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 2830607000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Common Stock Payments: -2425516000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -741796000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Construction In Progress: 168583000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 168583000.00
CMGS.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 8899394000.00
CMGS.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 2284739000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 301634000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 301634000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Current Assets: 1466953000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 1466953000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 302380000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 302380000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 302380000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 302380000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 240375000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 240375000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 240375000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 240375000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 1188142000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1188142000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Current Provisions: 39149000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Current Provisions: 39149000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Deferred Income Tax: 79483000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -14802000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Deferred Tax: 79483000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Deferred Tax: -14802000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 361382000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 92702000.00
CMGS.TO income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 361382000.00
CMGS.TO income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 92702000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 361382000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 92702000.00
CMGS.TO income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 361382000.00
CMGS.TO income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 92702000.00
CMGS.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 4758607737.00
CMGS.TO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 4678407757.00
CMGS.TO income_statement (annual, 2025-12-31) — Diluted EPS: 0.32
CMGS.TO income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.07
CMGS.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 1535761000.00
CMGS.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 330932000.00
CMGS.TO income_statement (annual, 2025-12-31) — EBIT: 2012808000.00
CMGS.TO income_statement (quarterly, 2025-12-31) — EBIT: 445729000.00
CMGS.TO income_statement (annual, 2025-12-31) — EBITDA: 2374190000.00
CMGS.TO income_statement (quarterly, 2025-12-31) — EBITDA: 538431000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -416000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -229000.00
CMGS.TO cash_flow (annual, 2025-12-31) — End Cash Position: 385909000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 385909000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: -2470898000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -741596000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: 1447590000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 228389000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -7289000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -7289000.00
CMGS.TO income_statement (annual, 2025-12-31) — General And Administrative Expense: 652017000.00
CMGS.TO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 160341000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Goodwill: 21939000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Goodwill: 21939000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 21939000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 21939000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 158136000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 158136000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 9673688000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 9673688000.00
CMGS.TO income_statement (annual, 2025-12-31) — Gross Profit: 3026207000.00
CMGS.TO income_statement (quarterly, 2025-12-31) — Gross Profit: 698772000.00
CMGS.TO income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 27503000.00
CMGS.TO income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 8464000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 423481000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 104477000.00
CMGS.TO income_statement (annual, 2025-12-31) — Interest Income: 73721000.00
CMGS.TO income_statement (quarterly, 2025-12-31) — Interest Income: 13324000.00
CMGS.TO income_statement (annual, 2025-12-31) — Interest Income Non Operating: 73721000.00
CMGS.TO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 13324000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Inventory: 49508000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Inventory: 49508000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Invested Capital: 2830607000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 2830607000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -35082000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -27746000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Investments And Advances: 197123000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 197123000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Land And Improvements: 12943000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 12943000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Leases: 3260533000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Leases: 3260533000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 4773434000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 4773434000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 4773434000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 4773434000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 321426000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 321426000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -2425516000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -741796000.00
CMGS.TO income_statement (annual, 2025-12-31) — Net Income: 1535761000.00
CMGS.TO income_statement (quarterly, 2025-12-31) — Net Income: 330932000.00
CMGS.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 1535761000.00
CMGS.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 330932000.00
CMGS.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 1535761000.00
CMGS.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 330932000.00
CMGS.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1535761000.00
CMGS.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 330932000.00
CMGS.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1535761000.00
CMGS.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 330932000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 1535761000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 330932000.00
CMGS.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 1535761000.00
CMGS.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 330932000.00
CMGS.TO income_statement (annual, 2025-12-31) — Net Interest Income: 73721000.00
CMGS.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: 13324000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 631254000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 169709000.00
CMGS.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 73721000.00
CMGS.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 13324000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -45382000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 200000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Net PPE: 7142371000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 7142371000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -666336000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -197455000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 2808668000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 2808668000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 125674000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 125674000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 125674000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 125674000.00
CMGS.TO income_statement (annual, 2025-12-31) — Normalized EBITDA: 2451200000.00
CMGS.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 563841000.00
CMGS.TO income_statement (annual, 2025-12-31) — Normalized Income: 1594615359.98
CMGS.TO income_statement (quarterly, 2025-12-31) — Normalized Income: 350323485.90
CMGS.TO balance_sheet (annual, 2025-12-31) — Notes Receivable: 4529000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Notes Receivable: 4529000.00
CMGS.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: 2113926000.00
CMGS.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 425844000.00
CMGS.TO income_statement (annual, 2025-12-31) — Operating Income: 2012808000.00
CMGS.TO income_statement (quarterly, 2025-12-31) — Operating Income: 445729000.00
CMGS.TO income_statement (annual, 2025-12-31) — Operating Revenue: 11925601000.00
CMGS.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 2983511000.00
CMGS.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 1304360000.00
CMGS.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 1304360000.00